• Mashup Score: 1

    Bladder cancer (BLCA) is the most common malignant tumor of the urinary system and is characterized by high metastatic rates and poor prognosis. The expression of tight junction protein 1 (TJP1) is associated with bladder cancer invasion; however, the mechanism by which TJP1 affects vasculature remodeling remains unknown. In this study, we found that TJP1 expression correlated with tumor…

    Tweet Tweets with this article
    • TJP1 promotes angiogenesis in bladder cancer cells via TWIST-dependent regulation of CCL2, says a new article in @oncogenejournal https://t.co/BoPd7pZgti

  • Mashup Score: 1

    As the p53 tumor suppressor is rarely mutated in conjunctival melanoma (CM), we investigated its activation as a potential therapeutic strategy. Preventing p53/Mdm2 interaction by Nutlin-3, the prototypical Mdm2 antagonist, or via direct siRNA Mdm2 depletion, increased p53 and inhibited viability in CM cell lines. The sensitivity to Nutlin-3 p53 reactivation with concomitant Mdm2 stabilization…

    Tweet Tweets with this article
    • Two targets for the price of one! Research led by @LGirnita at @karolinskainst identifies dual oncogene and tumour suppressor control via #Nutlin-3 that may finally bring precision oncology to #ConjunctivalMelanoma patients. πŸ‘‰https://t.co/J3ahsS99Km #Melanoma #TargetedTherapy

  • Mashup Score: 0

    We recently reported that genetic or pharmacological inhibition of insulin-like growth factor receptor (IGF-1R) slows DNA replication and induces replication stress by downregulating the regulatory subunit RRM2 of ribonucleotide reductase, perturbing deoxynucleotide triphosphate (dNTP) supply. Aiming to exploit this effect in therapy we performed a compound screen in five breast cancer cell lines…

    Tweet Tweets with this article
    • πŸ‘¨β€πŸ”¬πŸ‘©β€πŸ”¬ Exploiting the vulnerabilities of IGF-inhibited cells: @DrGuillaume_PhD & co-workers show that co-targeting IGF with CHK1 or WEE1 may have potential as a novel therapeutic strategy. πŸ‘‰ https://t.co/R2qwXex8JV

  • Mashup Score: 8

    Diffuse midline glioma (DMG) is a deadly pediatric and adolescent central nervous system (CNS) tumor localized along the midline structures of the brain atop the spinal cord. With a median overall survival (OS) of just 9–11-months, DMG is characterized by global hypomethylation of histone H3 at lysine 27 (H3K27me3), driven by recurring somatic mutations in H3 genes including, HIST1H3B/C…

    Tweet Tweets with this article
    • πŸ”Ž On genomic, non-genomic & exogenous factors that contribute to #DMG #DIPG initiation & progression. A systems-wide view to highlight factors that underpin poor outcomes and strategies to improve treatment. #OpenAccess from @MattDun17, @sebastianw & co: https://t.co/DPBwv7i682

  • Mashup Score: 11

    Diffuse midline glioma (DMG) is a deadly pediatric and adolescent central nervous system (CNS) tumor localized along the midline structures of the brain atop the spinal cord. With a median overall survival (OS) of just 9–11-months, DMG is characterized by global hypomethylation of histone H3 at lysine 27 (H3K27me3), driven by recurring somatic mutations in H3 genes including, HIST1H3B/C…

    Tweet Tweets with this article
    • Congrats to Izac, #DunLab, @sebastianw, @MattDun17, and the team on a truly in depth analysis in @oncogenejournal that will build toward real time testing of the proteomics of #DIPG/#DMG - critical to #CART. @seattlechildren #VitanzaLab #EndDIPG #EndDIPG https://t.co/6PRKdYq7NN https://t.co/wsHGsQuErH